The future of ERBB2 research is promising, with ongoing studies exploring its role in various cancers and expanding the arsenal of targeted therapies. Personalized medicine approaches, which tailor treatments based on the genetic profile of the tumor, are increasingly being integrated into clinical practice. Advances in genomic sequencing and biomarker discovery are expected to refine our understanding of ERBB2âs role, leading to more effective and individualized treatment strategies.
